Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
14.10Prev. Close
13.98Volume
65Total traded value
0.00 CrUpper Circuit
16.77Lower Circuit
11.18Fundamentals
| Market Cap | ₹315Cr |
| ROE | -17.19% |
| P/E Ratio(TTM) | -0.87 |
| EPS(TTM) | -16.12 |
| P/B Ratio | 0.44 |
| Dividend Yield | 0.00% |
| Industry P/E | 33.27 |
| Book Value | 31.97 |
| Debt to Equity | 0.64 |
| Face Value | 1 |
Understand Fundamentals
Financials
About Nectar Life Sciences
Nectar Lifesciences is a global pharmaceutical company from India that specializes in making a type of antibiotic called Cephalosporins. Its vision is to become India's leading global life sciences company that creates value for everyone by delivering excellence in products and services. The company is the world's leading producer of key active pharmaceutical ingredients like Cefixime Trihydrate, Cefuroxime Axetil, and other sterile APIs.;
| Parent Organisation | Nectar Life Sciences |
| Managing Director | Mr. Sanjiv Goyal |
| NSE Symbol | NECLIFE |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.21 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 31.69 | ||
| Cohance Lifesciences | NA (0.00%) | 71.09 | ||
| Wockhardt | NA (0.00%) | -423.74 |